Over 50 executive speakers and more than 200 expected attendees will explore “AI In Action,” advancing automation, GenAI, large language models, and real-world data across pharmacovigilance and regulatory operations.

Boston, Massachusetts, USA – February 18, 2025 – With just one month to go, ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, today announced an impressive lineup of speakers for Breakthrough 2025, the premier event for life sciences. Taking place March 18–19 in Zurich, Switzerland, this year’s theme, “AI In Action,” spotlights how generative AI is driving transformative advancements across the R&D IT ecosystem.

Senior executives across Safety and Regulatory at some of the most important names in life sciences – Amgen, Astellas Pharma, Boehringer Ingelheim, Bristol Myers Squibb, Johnson & Johnson, Merck, Roche, Opella — are among those who will discuss topics including maximizing ROI with new technology, change management and cultural considerations with the implementation of GenAI, and regulatory strategies for a rapidly changing environment.

At Breakthrough, ArisGlobal will announce the latest LifeSphere developments – specifically new GenAI and Agentic AI-enabled products that will continue to drive efficiencies and insights across Safety and Regulatory workflows.

What to expect:

• Breakthrough 2025 will feature more than 20 sessions and 50 executive speakers

• A deep dive into how LifeSphere NavaX GenAI is transforming pharmacovigilance and regulatory workflows, with insights from leading industry experts.

• Practical guidance on streamlining IT infrastructure to support AI-driven automation and ensure seamless compliance.

• Strategic discussions on the evolving regulatory landscape and how digital transformation is shaping the future of compliance and risk management.

• Mid and large-size pharmaceutical companies exploring the shift toward modular, GenAI-powered solutions across R&D.

• Exclusive access to the Breakthrough Innovation Center, where attendees can experience hands-on demos of the latest LifeSphere NavaX advancements.

Whether organizations are just beginning their AI journey or are looking to scale GenAI and large language model (LLM) applications across their R&D operations, Breakthrough 2025 will provide invaluable insights. Attendees will receive practical guidance on adopting AI technologies, learn from real-world use cases shared by industry pioneers, and gain expert technical knowledge to stay ahead in an industry that’s rapidly evolving.

“In the next 12 to 24 months, the life sciences industry will navigate critical shifts in pharmacovigilance and regulatory affairs, making collaboration more essential than ever. Convening together allows us to exchange insights, anticipate regulatory changes, and drive innovation that ensures patient safety and compliance,” shared Morgan Scott, Chief of Staff and Vice President of Communications and Marketing at ArisGlobal. “ArisGlobal is deeply invested in developing technology and services to support the industry’s evolving needs. By coming together at Breakthrough, we can shape the future, advance best practices, and build solutions that set new standards for excellence.”

ArisGlobal is proud to partner with leading organizations in sponsorship of Breakthrough 2025, including Adlib, AWS, Main5, Sitero, and Snowflake.

To register for Breakthrough, visit www.arisglobal.com/breakthrough.